Unraveling Modeling Challenges in the Economic Evaluations of Gene Therapies: A Global Review
![](https://connectheor.com/wp-content/uploads/2024/05/Rectangle-9585.jpg)
From Submission to Reimbursement: Navigating the COVID-19 Ripple Effect on Therapy Access in Canada
![](https://connectheor.com/wp-content/uploads/2024/05/Rectangle-9585.jpg)
Methodological Insights on Indirect Treatment Comparisons for Ulcerative Colitis Therapies in NICE Submissions
![](https://connectheor.com/wp-content/uploads/2024/05/Rectangle-9585.jpg)
Unleashing the Power of Social Media Listening: A Promising Tool for Patient-Focused Research
![](https://connectheor.com/wp-content/uploads/2024/05/Rectangle-9585.jpg)
Q-TWiST Analysis Is Back in the Game in Oncology Clinical Trial Analysis: A Recent Trend
![](https://connectheor.com/wp-content/uploads/2022/11/proportionate-approach-to-TAs.png)
Toxicity, Progression-Free Survival, and Quality of Life of Patients Treated with Zanubrutinib Versus Ibrutinib: A Q-TWiST Analysis from the ALPINE Study in Relapsed or Refractory Chronic Lymphocytic Leukemia
![](https://connectheor.com/wp-content/uploads/2021/05/Connectheor-techhub-1024x627.jpg)